Industry

SAN FRANCISCO–(BUSINESS WIRE)–$TIVC #healthcare—Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that it will report financial results for the second quarter of 2022 via conference call and webcast, Monday, August 15, 2022, at 1:30 pm PT / 4:30 pm ET. Teleconference Details: Toll-Free: 877-545-0320 … [Read more…]

PHILADELPHIA–(BUSINESS WIRE)–Aro Biotherapeutics, a biotechnology company pioneering the development of tissue-targeted genetic medicines, today announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation for ABX1100, an investigational Centyrin-siRNA conjugate that targets the Gys1 gene in the muscle, for the treatment of Pompe disease. “We are pleased to have received this designation … [Read more…]

BOSTON–(BUSINESS WIRE)–Manatt, Phelps & Phillips, LLP, a multidisciplinary, integrated professional services firm, announced today that Cynthia Bero has joined its Boston office as a Manatt Health senior advisor. Bero joins Manatt from Mass General Brigham (MGB), where she spent over 20 years in senior information technology positions, most recently as Vice President of Information Systems. … [Read more…]

Former Generate Biomedicines, Amgen and Novartis senior leader Mike Nohaile joins Prellis as CEO SAN FRANCISCO–(BUSINESS WIRE)–Prellis Biologics, Inc (Prellis Bio), a biotherapeutics company, today appointed Michael Nohaile, PhD as its new CEO and announced it has raised a $35 million Series C funding round, co-led by Celesta Capital and Avidity Partners with participation from … [Read more…]

OTTAWA, Onatrio–(BUSINESS WIRE)–#RailSafety—Operation Lifesaver (OL) Canada, a national not-for-profit dedicated to rail safety, today launched a new public-awareness campaign aimed at educating young Canadians about the importance of obeying all rail safety signs and signals. Designed to appeal to youth between 13 and 24, the Seriously. Read the Signs. campaign takes a light-hearted approach to … [Read more…]

— Transformational precision gene delivery company launched out of Versant’s Ridgeline Discovery Engine – — Vector developing platform for precisely targeted delivery of high-capacity genetic payloads — BASEL, Switzerland–(BUSINESS WIRE)–Versant Ventures today announced the debut of Vector BioPharma AG, a biopharmaceutical company developing a precision gene delivery platform that is devoid of viral genes. Versant … [Read more…]

BEDFORD, Mass.–(BUSINESS WIRE)–$OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will present at the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference on Wednesday, August 17, 2022: Pre-Recorded Corporate Presentation Date: Wednesday, August 17, 2022 … [Read more…]

Patient engagement leader expands commitment to driving digital health technology as pandemic continues BETHESDA, Md,–(BUSINESS WIRE)–#Adventist–Patients using a remote patient monitoring program developed by Get Well, a global leader in digital patient engagement, to monitor and report COVID-19 symptoms had lowered hospitalization rates, spent less time in the intensive care unit, and had shorter overall … [Read more…]

OB-GYN Practice in Florida Uses PatientPop Technology to Enhance Its Online Presence SANTA MONICA, Calif.–(BUSINESS WIRE)–PatientPop, a market leader in practice growth technology, today announced that its successful partnership with OB-GYN Dr. Alan B. Patterson has resulted in a significant increase in new patients and business outcomes. Dr. Patterson began leveraging PatientPop’s services in 2017 … [Read more…]

Achieved record net product revenue of $25.3M – a 15% increase from Q1 ’22, and a 34% increase from same period prior year on a pro forma basis Ended Q2 with $111.6M in cash, cash equivalents and short-term investments Reaffirms full-year total net product revenue of $105M-$120M; $50M in synergies by year-end, 2022 year-end cash … [Read more…]